|Articles|March 30, 2022
Winterlight Labs and Alzheimer Center Amsterdam Announce Collaboration
Organizations will decentralize patient assessments in preclinical Alzheimer’s disease research.
Advertisement
Winterlight Labs will collaborate with memory clinic, Alzheimer Center Amsterdam of Amsterdam UMC, to decentralize assessments of patients’ cognition and function in the study of preclinical Alzheimer’s disease.
Funded by the Dutch Ministry of Health (Health~Holland), Alzheimer Center Amsterdam will develop a remote measurement toolbox, integrating Winterlight’s digital speech assessments to help capture subtle changes in cognitive health. It is anticipated that the work will establish a validated approach to monitoring patients in the earliest stages of Alzheimer’s disease, and ultimately help to provide detailed measurements of the impact of preventative treatments.
Read more aout the collaboration here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement